Lipegfilgrastim may cause hyperleukocytosis.
Zekeriya HannariciAli YılmazMehmet Emin BuyukbayramAykut TurhanSalim Başol TekinMehmet BiliciPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Although lipegfilgrastim-induced hyperleukocytosis has not been reported in the literature, it should be borne in mind that hyperleukocytosis and related complications may occur, as in our case.